Sorrento Therapeutics, Inc. (SRNE:NASDAQ) rocketted at $3.11, representing a gain of 94.4%. The stock appeared on our News Catalysts scanner on Tue 12 Nov 19 at 12:41 PM in the 'MISCELLANEOUS' category.
About Sorrento Therapeutics, Inc. (SRNE:NASDAQ)
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
Top 10 Gainers:
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 94.38%
- JanOne Inc. (JAN:NASDAQ), 54.51%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 51.61%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 44.25%
- CPI Card Group Inc. (PMTS:NASDAQ), 35.48%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 28.98%
- Ideanomics, Inc. (IDEX:NASDAQ), 27.14%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 24.55%
- The Medicines Company (MDCO:NASDAQ), 22.25%
- Neoleukin Therapeutics, Inc. (NLTX:NASDAQ), 22.19%